Literature DB >> 11468686

Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

L A Metherell1, S A Akker, P B Munroe, S J Rose, M Caulfield, M O Savage, S L Chew, A J Clark.   

Abstract

Inherited growth-hormone insensitivity (GHI) is a heterogeneous disorder that is often caused by mutations in the coding exons or flanking intronic sequences of the growth-hormone receptor gene (GHR). Here we describe a novel point mutation, in four children with GHI, that leads to activation of an intronic pseudoexon resulting in inclusion of an additional 108 nt between exons 6 and 7 in the majority of GHR transcripts. This mutation lies within the pseudoexon (A(-1)-->G(-1) at the 5' pseudoexon splice site) and, under in vitro splicing conditions, results in inclusion of the mutant pseudoexon, whereas the wild-type pseudoexon is skipped. The presence of the pseudoexon results in inclusion of an additional 36-amino acid sequence in a region of the receptor known to be involved in homo-dimerization, which is essential for signal transduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468686      PMCID: PMC1235493          DOI: 10.1086/323266

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  The DNA sequence of human chromosome 22.

Authors:  I Dunham; N Shimizu; B A Roe; S Chissoe; A R Hunt; J E Collins; R Bruskiewich; D M Beare; M Clamp; L J Smink; R Ainscough; J P Almeida; A Babbage; C Bagguley; J Bailey; K Barlow; K N Bates; O Beasley; C P Bird; S Blakey; A M Bridgeman; D Buck; J Burgess; W D Burrill; K P O'Brien
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Multiple splicing defects in an intronic false exon.

Authors:  H Sun; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences.

Authors:  M Krawczak; J Reiss; D N Cooper
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

4.  Hierarchy for 5' splice site preference determined in vivo.

Authors:  A L Lear; L P Eperon; I M Wheatley; I C Eperon
Journal:  J Mol Biol       Date:  1990-01-05       Impact factor: 5.469

5.  A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution.

Authors:  Z A Dwi Pramono; Y Takeshima; A Surono; T Ishida; M Matsuo
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

6.  Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA.

Authors:  M Aebi; H Hornig; R A Padgett; J Reiser; C Weissmann
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

7.  Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein.

Authors:  C R Buchanan; H G Maheshwari; M R Norman; D J Morrell; M A Preece
Journal:  Clin Endocrinol (Oxf)       Date:  1991-08       Impact factor: 3.478

8.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule.

Authors:  B C Cunningham; M Ultsch; A M De Vos; M G Mulkerrin; K R Clauser; J A Wells
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

9.  Laron dwarfism and mutations of the growth hormone-receptor gene.

Authors:  S Amselem; P Duquesnoy; O Attree; G Novelli; S Bousnina; M C Postel-Vinay; M Goossens
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

10.  A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human beta-glucuronidase gene.

Authors:  R Vervoort; R Gitzelmann; W Lissens; I Liebaers
Journal:  Hum Genet       Date:  1998-12       Impact factor: 4.132

View more
  25 in total

Review 1.  Growth hormone and IGF-1.

Authors:  Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

2.  An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon.

Authors:  Sushma-Nagaraja Grellscheid; Christopher W J Smith
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.

Authors:  Zhujun Zhang; Yasuaki Habara; Atsushi Nishiyama; Yoshinobu Oyazato; Mariko Yagi; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2007-06-20       Impact factor: 3.172

Review 4.  Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

Authors:  Helen L Storr; Sumana Chatterjee; Louise A Metherell; Corinne Foley; Ron G Rosenfeld; Philippe F Backeljauw; Andrew Dauber; Martin O Savage; Vivian Hwa
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 5.  Deep intronic mutations and human disease.

Authors:  Rita Vaz-Drago; Noélia Custódio; Maria Carmo-Fonseca
Journal:  Hum Genet       Date:  2017-05-12       Impact factor: 4.132

6.  Cryptic exon activation by disruption of exon splice enhancer: novel mechanism causing 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  Martin Stucki; Terttu Suormala; Brian Fowler; David Valle; Matthias R Baumgartner
Journal:  J Biol Chem       Date:  2009-08-24       Impact factor: 5.157

7.  An FBN1 pseudoexon mutation in a patient with Marfan syndrome: confirmation of cryptic mutations leading to disease.

Authors:  Dong-Chuan Guo; Prateek Gupta; Van Tran-Fadulu; Tera V Guidry; Magalie S Leduc; Frederick V Schaefer; Dianna M Milewicz
Journal:  J Hum Genet       Date:  2008-09-17       Impact factor: 3.172

8.  Infertile Finnish Yorkshire boars carry a full-length LINE-1 retrotransposon within the KPL2 gene.

Authors:  Anu Sironen; Johanna Vilkki; Christian Bendixen; Bo Thomsen
Journal:  Mol Genet Genomics       Date:  2007-07-04       Impact factor: 3.291

9.  Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity.

Authors:  A David; F Miraki-Moud; N J Shaw; M O Savage; A J L Clark; L A Metherell
Journal:  Eur J Endocrinol       Date:  2009-10-07       Impact factor: 6.664

Review 10.  The continuum between GH deficiency and GH insensitivity in children.

Authors:  Martin O Savage; Helen L Storr; Philippe F Backeljauw
Journal:  Rev Endocr Metab Disord       Date:  2020-10-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.